Zhongnan Medical Journal Press

Home Results

A total of 14 result was found. Results that relate to Hepatocellular carcinoma

Analysis of the expression of TMEM88 in hepatocytes and its relationship with prognosis based on TCGA and other databases

Published on Journal of Mathematical Medicine 2023,36(4):267-281.
11264 times 2222 times

Andrew Liman Qian ZHU

Bioinformatic Transmembrane protein 88 Hepatocellular Carcinoma
Details
Current perspectives on tertiary lymphoid structures and PD-1/PD-L1 signaling pathway in the immunotherapy of hepatocellular carcinoma

Published on New Medicine 2023,33(5):373-380.
10619 times 2657 times

Hao-Dong QIAO Yi-Fan LIU Ze LIANG Huai-Bin GUO

Hepatocellular carcinoma Immunotherapy PD-1/PD-L1 signaling pathway Tertiary lymphoid structures
Details
Cost-utility analysis of tislelizumab versus sorafenib as first-line treatment for advanced unresectable hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2024,27(1):109-116.
8237 times 2004 times

SU Zhan CHE Jinhui PEI Ruifeng

Hepatocellular carcinoma Tislelizumab Sorafenib Partition survival model Pharmacoeconomic analysis
Details
Real-world study of sintilimab combined with bevacizumab in patients with advanced hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):485-490.
12743 times 2449 times

SU Zhan CHE Jinhui PEI Ruifeng

Advanced hepatocellular carcinoma Sintilimab Bevacizumab Clinical efficacy Safety Overall survival Progression-free survival
Details
Efficacy and safety of tislelizumab combined with sorafenib in the treatment for unresectable hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2024,27(8):1136-1342.
9873 times 2096 times

JIANG Jinghua HU Yiting

Tirilizumab Sorafenib Unresectable Hepatocellular carcinoma Objective response rate Disease control rate Progression-free survival Overall survival
Details
Causal association between systemic inflammatory factors and the risk of hepatocellular carcinoma based on Mendelian randomization

Published on Journal of Mathematical Medicine 2024,37(8):592-599.
15701 times 2451 times

LI Xinyu NIE Duorui XIAO Tingfen CAO Jun WANG Zhiqi XU Fei CHEN Chang

Inflammatory factors Hepatocellular carcinoma Mendelian randomization analysis GWAS
Details
Exploring the medication rules of hepatic precancerous lesions based on data mining

Published on Frontiers in Pharmaceutical Sciences 2024,28(1):80-89.
10868 times 1607 times

GOU Siyuan YANG Xianzhao WANG Longzhu TIAN Yujia RU Shuying

Hepatocellular carcinoma Precancerous lesions Traditional Chinese medicine Data mining Medication rule Milkvetch root Largehead atractylodes rhizome Radix salviae miltiorrhhizae
Details
Analysis and prediction model construction of infection after transcatheter arterial chemoembolization in hepatocellular carcinoma patients

Published on New Medicine 2024,34(12):1345-1356.
13796 times 2187 times

DU Jiao DA Xiuwei ZHANG Qing YAN Yan LIU Dan GAO Nan GAO Min ZHANG Hongxin WANG Miaomiao

Hepatocellular carcinoma Transcatheter arterial chemoembolization Pathogenic bacteria Infection Prediction model
Details
Mendelian randomization and bioinformatics analysis of TRIM31 with chronic liver disease

Published on New Medicine 2025,35(3):303-311.
10997 times 2153 times

YOU Junyi LIANG Guoqiang SONG Xiudao

Mendelian randomization Tripartite motif 31 Chronic liver disease Hepatocellular carcinoma Bioinformatics
Details
Study of the correlation between PTTG1 gene expression and hepatocellular carcinoma based on integrative bioinformatics

Published on Journal of Mathematical Medicine 2025,38(7):518-526.
12889 times 1798 times

ZOU Yuhui DUAN Hui WU Jingchun SU Qian

PTTG1 gene Hepatocellular carcinoma Bioinformatics
Details
Bibliometric analysis of the research hotspots and trends related to Zheng Gan decoction

Published on Frontiers in Pharmaceutical Sciences 2025,29(7):1215-1223.
10916 times 1648 times

SONG Tianli WANG Yiming LIU Xu XIANG Dehuang HUANG Sheng RAN Yun

Bibliometrics Zheng Gan decoction Hepatocellular carcinoma Anti-tumour Apoptosis
Details
Systematic review and Meta-analysis of prediction models: a case study on the risk prediction model for hepatocellular carcinoma in patients with chronic hepatitis B

Published on New Medicine 2025,35(8):861-869.
11693 times 1866 times

LIU Haorui ZHOU Yesheng LI Yuge YU Shuang SUN Feng WU Shanshan

Prediction models Systematic review Meta-analysis Risk of bias assessment Hepatocellular carcinoma Chronic hepatitis B
Details
A case analysis of lenvatinib-induced proteinuria renal injury in patient with metastatic hepatocellular carcinoma after liver transplant

Published on Chinese Journal of Pharmacoepidemiology 2026,35(2):215-220.
4222 times 898 times

ZHENG Xinyi WANG Xiaohang SU Yingjie

Hepatocellular carcinoma Post liver transplantation Bone metastases Lenvatinib Proteinuria Drug-induced renal injury Pharmaceutical care
Details
Integrating network pharmacology and molecular docking to elucidate the therapeutic mechanisms of Foeniculum vulgare against hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2026,30(3):361-370.
5172 times 828 times

DENG Xiaying ZHAO Xiangxuan

Foeniculum vulgare Network pharmacology Network targets Hepatocellular carcinoma Mechanism of action Molecular docking Targeted therapy Natural products
Details